To the Editor Americans 65 years and older are the fastest growing segment of the population.1 Traumatic brain injury (TBI)-related hospitalizations and mortality have increased significantly among this group,2 with the widespread use of oral anticoagulant (OAC) medications having obvious implications. There are no guidelines regarding resumption of OACs following TBI in these patients.
Grandhi R, Shutter LA, Okonkwo DO. Risks and Benefits of Resumption of Anticoagulation Following Traumatic Brain Injury Remain Complex and Uncertain. JAMA Intern Med. 2015;175(5):866. doi:10.1001/jamainternmed.2015.0298
Monkeypox Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.